Overview
Duolife is a company that offers food supplements designed to support the body's circadian rhythm, including their flagship DUOLIFE Day and Night set. They provide a variety of products such as liquid supplements, capsules, and cosmetics, as well as pre-made product sets developed by experts.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-10-08. Active
13 1050 1445 1000 0090 8068 0516
16 1050 1445 1000 0090 3167 0145
17 1050 1445 1000 0090 8166 6449
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 23, 2020 | Commercial Companies Code notice | |
| Dec 2, 2020 | Commercial Companies Code notice | |
| Nov 10, 2020 | Commercial Companies Code notice | |
| Oct 21, 2020 | Commercial Companies Code notice | |
| Sep 30, 2020 | Commercial Companies Code notice |
Public aid
10 public aid cases recorded, with a total value of $661,378.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 21, 2025 | Regional investment aid | $591.2K$591,226 | Marszałek Województwa Małopolskiego | |
| Feb 21, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $14,189$14,189 | Marszałek Województwa Małopolskiego | |
| May 16, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,883$2,883 | Polska Agencja Inwestycji I Handlu S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-06-01 | Rozwój infrastruktury niezbędnej dla prowadzenia prac B+R w przedsiębiorstwie Duolife S.A. | $604.0K$604,050 | Fundusze Europejskie dla Małopolski 2021-2027 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Łukasz Godyń (41) | Osoba fizyczna zajmująca wyższe stanowisko kierownicze w spółce | |
Bartosz Jacek Królikowski (46) | Osoba fizyczna zajmująca wyższe stanowisko kierownicze w spółce |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Bionateosp. z o.o. | 270.12 USD | 20% | ||
Royal Investment Fleetsp. z o.o. | 21,609.94 USD | 80% | ||
Royal Investment Groupsp. z o.o. | 21,609.94 USD | 80% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Unilever PolskaS.A. | $163,896,003.62 | unilever.pl | ||
| Herbapol - LublinS.A. | $162,768,581.04 | herbapol.com.pl | ||
| NTFYsp. z o.o. | $79,592,319.96 | ntfy.pl | ||
| Oleofarmsp. z o.o. | $68,110,367.86 | oleofarm.pl | ||
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| Master PharmS.A. | $23,116,954.19 | masterpharm.pl | ||
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| CelikoS.A. | $13,080,041.65 | celiko.com.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu |
Change history
| Date | Event | |
|---|---|---|
| 2022-04-12 | Share capital change (109,392.30 PLN → 110,565.40 PLN) | |
| 2021-07-20 | Share capital change (106,074.90 PLN → 109,392.30 PLN) | |
| 2021-03-11 | Share capital change (101,926.50 PLN → 106,074.90 PLN) | |
| 2021-01-21 | Share capital change (100,000.00 PLN → 101,926.50 PLN) | |
| 2018-02-08 | PKD change (Removed: 62.02.Z, 73.20.Z, 85.51.Z, 85.60.Z; Added: 64.20.Z, 64.99.Z, 68.10.Z, 82.99.Z) |
FAQ
Last updated: 2026-03-27